Unlocking International Biotech Innovation: Your Guide to the EUROKA Network Biotechnology 2026 Call

Introduction

The biotechnology sector stands at the forefront of solving some of the world's most pressing challenges-from developing new therapies and sustainable agricultural practices to creating bio-based materials and advanced diagnostics. In this dynamic landscape, international collaboration is not just beneficial; it is essential. The EUROKA Network Biotechnology 2026 Call presents a unique and timely opportunity for Turkish research and innovation consortia to secure funding for ambitious, cross-border projects.

Announced by the Boğaziçi University Project Office, this call is designed to support collaborative research and innovation projects in biotechnology. It is open to Turkish legal entities, but with a clear structure: the project coordinator must be a company, and at least one additional company must participate as a partner. This industry-centric model ensures that projects are not only scientifically rigorous but also commercially viable and market-oriented.

What is the EUROKA Network?

The EUROKA Network is a well-established European framework that supports bottom-up, market-driven collaborative R&D projects. It brings together partners from different countries to develop innovative products, processes, or services. The network’s approach is pragmatic: it funds projects that have a clear path to commercialization, making it an ideal platform for biotech ventures that aim to translate lab discoveries into real-world applications.

For Turkey, participation in EUROKA calls like the Biotechnology 2026 Call is a strategic move. It aligns with the country's goals of increasing its innovation capacity, fostering international partnerships, and boosting its standing in the global biotech arena.

Key Details of the Call

• Official Title: EUROKA Network Biotechnology 2026 Call
• Organiser: EUROKA Network
• Type: Research Grant
• Status: Open
• Opens: 31 March 2026
• Deadline: 18 November 2026
• Geographic Restrictions: Turkey
• Rolling Submission: No (fixed deadline)
• Source URL: Boğaziçi University Project Office
• Apply URL: TÜBİTAK Application Portal

Note: Specific funding amounts are not publicly specified for this call, which is common for EUROKA Network projects where funding depends on national budgets and project scope. Applicants should prepare a detailed budget and consult with TÜBİTAK (the Scientific and Technological Research Council of Turkey) for guidance.

Eligibility: Who Can Apply?

The call is open to Turkish legal entities, including:

• Companies of any size
• Higher education institutions (universities)
• Public research centers and institutes
• Education and research hospitals
• Research infrastructures defined under Law No. 6550

However, there are two critical structural requirements:

1. The project coordinator must be a company. This means a commercial entity must lead the consortium.
2. At least one additional company must participate as a project partner.

This requirement underscores the call’s focus on industry-driven innovation. While universities and research centers can (and should) participate, the leadership must come from the private sector, ensuring that the project has a clear commercial orientation.

Why This Call Matters for Turkish Biotech

1. Access to International Markets and Partners

By participating in a EUROKA project, Turkish companies can collaborate with leading biotech firms, research institutes, and universities across Europe and beyond. This opens doors to new markets, technologies, and expertise that may not be available domestically.

2. Industry-Driven Innovation

The requirement for company leadership means that projects will be grounded in real market needs. This increases the likelihood of successful commercialization and return on investment.

3. Leveraging Turkey’s Strengths

Turkey has a growing biotech ecosystem, with strong capabilities in pharmaceuticals, medical devices, diagnostics, and agricultural biotechnology. This call allows Turkish entities to build on these strengths in an international context.

4. Support from TÜBİTAK

TÜBİTAK is the national funding body that manages Turkish participation in EUROKA. It provides guidance, co-funding, and a streamlined application process through the PRODİS portal.

How to Prepare a Strong Application

Step 1: Form Your Consortium

• Identify a lead company that will act as coordinator. This company should have a strong R&D track record and the capacity to manage an international project.
• Recruit at least one additional company as a partner. Different types of companies (SMEs, large firms) can bring complementary skills.
• Include research partners (universities, research centers, hospitals) to add scientific depth.
• Consider partners from other EUROKA member countries to strengthen the international dimension.

Step 2: Define Your Project

• Focus on biotechnology: The call is broad, covering any area of biotechnology-medical, industrial, agricultural, environmental, etc.
• Ensure innovation: The project must go beyond the state of the art. It should develop a new product, process, or service with clear market potential.
• Plan for commercialisation: EUROKA projects are expected to lead to a tangible outcome, such as a prototype, patent, or new product.

Step 3: Develop a Strong Proposal

• Write a clear project description with well-defined objectives, work packages, and deliverables.
• Highlight the consortium’s complementary expertise.
• Include a realistic budget that covers personnel, equipment, travel, and other costs.
• Demonstrate the project’s impact on the Turkish biotech sector and the broader economy.

Step 4: Submit via TÜBİTAK

• Applications must be submitted through the TÜBİTAK PRODİS portal (https://eteydeb.tubitak.gov.tr/prodis.htm).
• Ensure all partners are registered and have the necessary documentation.
• Adhere to the deadline: 18 November 2026.

Common Pitfalls to Avoid

• Missing the coordinator requirement: If the lead partner is not a company, the application will be rejected.
• Insufficient business involvement: Having only one company (the coordinator) may weaken the proposal. Additional companies strengthen the market focus.
• Lack of international partners: While not mandatory, involving partners from other EUROKA countries can improve the project’s chances.
• Poor budget justification: Even though funding amounts are not specified, a detailed budget is essential.

The Broading Perspective

The EUROKA Network Biotechnology 2026 Call is part of a larger trend in research funding: moving towards mission-oriented, industry-led consortia. For Turkey, this aligns with national strategies to increase R&D spending, foster public-private partnerships, and integrate Turkish innovators into global value chains.

For individual researchers and companies, this call represents a chance to do transformative science that has a real-world impact. It is not just about getting funding; it is about building lasting collaborations, accessing new expertise, and creating products that can change lives.

Conclusion

The EUROKA Network Biotechnology 2026 Call is a golden opportunity for Turkish biotech consortia to launch ambitious international projects. With a focus on industry leadership, it ensures that projects are not only innovative but also commercially relevant. The deadline is 18 November 2026, so start building your consortium now, define your project, and prepare your application through the TÜBİTAK portal.

Don’t miss this chance to be part of a global network of innovators. The future of biotechnology is collaborative-and this call is your invitation to join.